Esbriet Divesting to Legacy Pharmaceuticals on November 3, 2025
Effective November 3, 2025, Legacy will take over the supply, distribution, and sales of Esbriet®
(pirfenidone) in the US.
Product Availability:
Genentech will continue accepting and fulfilling commercial orders for Esbriet until 12:00 p.m. PT (noon) on October 29, 2025. Any orders received on or after 12:00 p.m. PT (noon) on October 29, 2025 will be canceled.
Starting November 3, 2025 to access Esbriet please contact Legacy Pharma Inc:
[email protected] or phone: 1-800-727-7151.
Order Hemlibra Online
Customers who have entered into direct distribution agreements with Genentech to purchase Hemlibra can order it online.
To reorder a replacement ancillary tool, including Initial Fill Needles,Refill Needles, and Explant Tool, please
contact your Surgical Device Specialist (SDS) first, to complete the request.
If further assistance is needed, you may also contact Synergistix at (866) 736-2717.
For additional order and returns questions please contact Genentech Customer Service at 800-551-2231.
Request Products for Research or Clinical Trials
Genentech permits authorized organizations to use our products for research or clinical trials conducted in the United States.
Specialty pharmacies and infusion centers interested in limited distribution Genentech products may request access to purchase those products from an authorized wholesaler or specialty distributor.